Harpoon Therapeutics Inc.

NASDAQ: HARP · Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM

Harpoon Therapeutics Revenue Breakdown

Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Collaboration And License Revenue 31.91M 23.65M 17.44M 5.78M
Collaboration And License Revenue Growth +34.92% +35.60% +201.96% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selling, General, and Administrative Revenue 4.26M 3.8M 4.18M 3.85M 4.53M 5.06M 5.4M 5.2M 4.19M 4.33M 4.6M 3.92M 4.43M 3.94M 3.91M 4.33M 8.49M 3.73M 5.83M 2.21M 1.94M 967K 982K 912K
Selling, General, and Administrative Revenue Growth +12.07% -9.13% +8.59% -14.90% -10.55% -6.26% +3.83% +24.27% -3.44% -5.84% +17.33% -11.38% +12.24% +0.82% -9.69% -48.98% +127.45% -35.97% +163.30% +14.06% +100.83% -1.53% +7.68% n/a
Research and Development Revenue 12.32M 12.2M 15.16M 18.95M 20.98M 20.65M 20.82M 20.66M 16.97M 18.27M 16.22M 15.06M 13.06M 11.92M 12.52M 12.71M 9.53M 9.97M 9.38M 8.72M 5.97M 6.15M 5.53M 4.79M
Research and Development Revenue Growth +1.06% -19.57% -19.97% -9.68% +1.58% -0.80% +0.75% +21.75% -7.10% +12.67% +7.64% +15.38% +9.50% -4.75% -1.47% +33.28% -4.39% +6.28% +7.63% +46.09% -2.99% +11.17% +15.51% n/a